Haydeh Payami

16.3k citations

97 papers · 7.4k indexed · 3 hit papers · h-index 47

Impact in

Neurology top 0.1%
- Parkinson's Disease Mechanisms and Treatments
- Neurological diseases and metabolism
- Neurological disorders and treatments
- Neuroinflammation and Neurodegeneration Mechanisms
Biological Psychiatry top 1%

Papers in

Neurology 56
- Parkinson's Disease Mechanisms and Treatments 54
- Neurological diseases and metabolism 19
Cellular and Molecular Neuroscience 23
- Nuclear Receptors and Signaling 16

Co-authors: Cyrus P. Zabetian Stewart A. Factor Jeffrey Kaye John G. Nutt Eric Molho Erin M. Hill‐Burns Gerard P. Sexton Zachary D. Wallen
Journals: Movement Disorders (10 papers)Neurology (9 papers)Genetic Epidemiology (6 papers)The American Journal of Human Genetics (5 papers)Annals of Neurology (5 papers)
Partner nations: United States Sweden Canada

In The Last Decade

Haydeh Payami

97 papers receiving 7.2k citations

Hit Papers

align trajectories log scale

Metagenomics of Parkinson’s disease implicates the gut microbiome in multiple disease mechanisms 2022 · 176 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2022 Nature Communications
2017 Movement Disorders
2010 Nature Genetics

Peers

Countries citing papers authored by Haydeh Payami

Since Specialization

Citations

This map shows the geographic impact of Haydeh Payami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haydeh Payami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haydeh Payami more than expected).

Fields of papers citing papers by Haydeh Payami

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haydeh Payami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haydeh Payami. The network helps show where Haydeh Payami may publish in the future.

Co-authors

The 25 scholars most cited alongside Haydeh Payami, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Haydeh Payami Line = papers co-authored together Haydeh Payami links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Population fraction of Parkinson’s disease attributable to preventable risk factors npj Parkinson s Disease ·Haydeh Payami, Gwendolyn Cohen, Charles Murchison, Timothy R. Sampson, David G. Standaert, Zachary D. Wallen	2023	9
2	Metagenomics of Parkinson’s disease implicates the gut microbiome in multiple disease mechanisms Nature Communications ·Zachary D. Wallen, Ayşe Demirkan, Guy Twa, Gwendolyn Cohen, Marissa Dean, David G. Standaert, Timothy R. Sampson, Haydeh Payami Hit paper breakdown →	2022	176
3	Exploring human-genome gut-microbiome interaction in Parkinson’s disease npj Parkinson s Disease ·Zachary D. Wallen, William J. Stone, Stewart A. Factor, Eric Molho, Cyrus P. Zabetian, David G. Standaert, Haydeh Payami	2021	29
4	Caffeine, creatine, GRIN2A and Parkinson's disease progression Journal of the Neurological Sciences ·David K. Simon, Cai Wu, Barbara C. Tilley, Katja Lohmann, Christine Klein, Haydeh Payami, Anne‐Marie Wills, Michael J. Aminoff, Jacquelyn Bainbridge, Richard B. Dewey, Robert A. Hauser, Susen Schaake, Jay S. Schneider, Saloni Sharma, Carlos Singer, Caroline M. Tanner, Daniel Truong, Peng Wei, Pei Shieen Wong, Tianzhong Yang	2017	26
5	The heritability of risk and age at onset of Parkinson's disease after accounting for known genetic risk factors Journal of Human Genetics ·Taye H. Hamza, Haydeh Payami	2010	55
6	Lack of evidence for an association between UCHL1 S18Y and Parkinson’s disease European Journal of Neurology ·Carolyn M. Hutter, Ali Samii, Stewart A. Factor, John G. Nutt, Donald S. Higgins, Thomas D. Bird, Alida Griffith, John W. Roberts, Berta C. Leis, Jennifer S. Montimurro, Denise M. Kay, Karen L. Edwards, Haydeh Payami, Cyrus P. Zabetian	2008	25
7	Combined effects of smoking, coffee, and NSAIDs on Parkinson's disease risk Movement Disorders ·Karen M. Powers, Denise M. Kay, Stewart A. Factor, Cyrus P. Zabetian, Donald S. Higgins, Ali Samii, John G. Nutt, Alida Griffith, Berta C. Leis, John W. Roberts, Erica Martinez, Jennifer S. Montimurro, Harvey Checkoway, Haydeh Payami	2007	105
8	Association analysis of MAPT H1 haplotype and subhaplotypes in Parkinson's disease Annals of Neurology ·Cyrus P. Zabetian, Carolyn M. Hutter, Stewart A. Factor, John G. Nutt, Donald S. Higgins, Alida Griffith, John W. Roberts, Berta C. Leis, Denise M. Kay, Dora Yearout, Jennifer S. Montimurro, Karen L. Edwards, Ali Samii, Haydeh Payami	2007	113
9	Validity and Utility of a LRRK2 G2019S Mutation Test for the Diagnosis of Parkinson's Disease Genetic Testing ·Denise M. Kay, T. Bird, Cyrus P. Zabetian, Stewart A. Factor, Ali Samii, Donald S. Higgins, John G. Nutt, John W. Roberts, Alida Griffith, Berta C. Leis, Jennifer S. Montimurro, Sean Philpott, Haydeh Payami	2006	17
10	Profile of families with parkinsonism‐predominant spinocerebellar ataxia type 2 (SCA2) Movement Disorders ·Sarah Furtado, Haydeh Payami, Paul J. Lockhart, Melissa Hanson, John G. Nutt, Andrew A. Singleton, Amanda Singleton, J. D. Bower, Ryan J. Utti, Thomas D. Bird, Raúl de la Fuente‐Fernández, Yoshio Tsuboi, Mary Lou Klimek, Oksana Suchowersky, John Hardy, Donald B. Calne, Zbigniew K. Wszołek, Matthew J. Farrer, Katrina Gwinn, A. Jon Stoessl	2004	86
11	Accurate Determination of Ataxin-2 Polyglutamine Expansion in Patients with Intermediate-Range Repeats Genetic Testing ·Jennifer Hussey, Paul J. Lockhart, William Seltzer, Zbigniew K. Wszołek, Haydeh Payami, Melissa Hanson, Katrina Gwinn, Matthew J. Farrer	2002	14
12	Independent Predictors of Cognitive Decline in Healthy Elderly Persons Archives of Neurology ·Scott Marquis, M. M. Moore, Diane B. Howieson, Gerard P. Sexton, Haydeh Payami, Jeffrey Kaye, Richard Camicioli	2002	269
13	Expression of α-synuclein in the human brain: relation to Lewy body disease Molecular Brain Research ·Karin Wirdefeldt, Nenad Bogdanović, Lisa S. Westerberg, Haydeh Payami, Martin Schalling, Geoffrey Murdoch	2001	24
14	Age at onset of Parkinson disease and apolipoprotein E genotypes American Journal of Medical Genetics ·Sepideh Zareparsi, Richard Camicioli, Gerard P. Sexton, Thomas D. Bird, Phillip D. Swanson, Jeffrey Kaye, John G. Nutt, Haydeh Payami	2001	52
15	The Number of Trait Loci in Late-Onset Alzheimer Disease The American Journal of Human Genetics ·E. Warwick Daw, Haydeh Payami, Ellen Nemens, David Nochlin, Thomas D. Bird, Gerard D. Schellenberg, Ellen M. Wijsman	2000	213
16	Cognitive Markers Preceding Alzheimer's Dementia in the Healthy Oldest Old Journal of the American Geriatrics Society ·Diane B. Howieson, A. Dame, Richard Camicioli, Gerard P. Sexton, Haydeh Payami, Jeffrey Kaye	1997	167
17	Increased risk of familial late-onset Alzheimer's disease in women Neurology ·Haydeh Payami, Kim R. Montee, Holly Grimslid, S. Shattuc, Jeffrey Kaye	1996	31
18	No evidence for association of familial Parkinson's disease with CAG repeat expansion Neurology ·R. Carrero-Valenzuela, K Lindblad, Haydeh Payami, William G. Johnson, Martin Schalling, Edward S. Stenroos, S. Shattuc, John G. Nutt, Alexis Brice, M. Litt	1995	22
19	Increased risk of Parkinson's disease in parents and siblings of patients Annals of Neurology ·Haydeh Payami, Kimberly Larsen, Steven Bernard, John Nutt	1994	164
20	Relative predispositional effects (RPEs) of marker alleles with disease: HLA-DR alleles and Graves disease. PubMed ·Haydeh Payami, Sung-Hong Joe, Nadir R. Farid, V. Stenszky, S. H. Chan, P P Yeo, J. S. Cheah, G. Thomson	1989	170

About Haydeh Payami

Haydeh Payami is a scholar working on Neurology, Neurology, Cellular and Molecular Neuroscience, Biological Psychiatry and Physiology, having authored 97 papers that have together received 7.4k indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (54 papers), Alzheimer's disease research and treatments (26 papers), Neurological diseases and metabolism (19 papers), Nuclear Receptors and Signaling (16 papers), RNA regulation and disease (11 papers), Dementia and Cognitive Impairment Research (10 papers), Autism Spectrum Disorder Research (10 papers) and Genetic Associations and Epidemiology (9 papers). The work is most often cited by research in Neurology (3.7k citations), Neurology (1.6k citations), Biological Psychiatry (270 citations), Physiology (2.6k citations) and Cellular and Molecular Neuroscience (1.7k citations). Haydeh Payami has collaborated with scholars based in United States, Sweden and Canada. Frequent co-authors include Cyrus P. Zabetian, Stewart A. Factor, Jeffrey Kaye, John G. Nutt, Eric Molho, Erin M. Hill‐Burns, Gerard P. Sexton, Zachary D. Wallen, Denise M. Kay and Ellen M. Wijsman. Their work appears in journals such as Movement Disorders, Neurology, Genetic Epidemiology, The American Journal of Human Genetics and Annals of Neurology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact